
For women planning to conceive, understanding fertility potential is essential. One of the most important markers used by fertility specialists is Anti-Müllerian Hormone (AMH), a hormone that reflects ovarian reserve — meaning the number of eggs remaining in the ovaries. Unlike other fertility tests that fluctuate during the menstrual cycle, AMH provides a stable and reliable picture of egg quantity.
Despite its importance, many women are unaware of what AMH levels truly indicate or how they influence fertility, IVF success, and long-term reproductive planning. Low AMH does not automatically mean infertility, and high AMH is not always a sign of perfect fertility — which is why proper interpretation is crucial.
Dr. Sangeeta Dubey emphasizes that understanding your AMH and ovarian reserve empowers women to make informed choices about when to conceive, whether to consider egg freezing, and when to seek early fertility support. This knowledge can reduce anxiety, prevent delays in treatment, and help set realistic, personalized expectations for future family planning.
AMH, or Anti-Müllerian Hormone, is produced by small follicles in the ovaries. It serves as an indicator of the quantity of a woman’s remaining eggs, which is often referred to as ovarian reserve.
AMH levels are not influenced by the menstrual cycle, making it a convenient and reliable test for fertility assessment.
Ovarian reserve plays a significant role in fertility because:
It is important to interpret AMH results along with age, antral follicle count, and other fertility tests to get a complete picture.
Dr. Sangeeta Dubey advises that AMH testing is not a prediction of pregnancy success, but a valuable tool for planning and decision-making.
AMH levels gradually decline with age. Significant drops may occur after 35, but small fluctuations are normal.
Not necessarily. Women with low AMH can still conceive naturally, but fertility may decline faster, and interventions might be recommended.
AMH testing is useful for women planning pregnancy, those with irregular cycles, a history of infertility, or at risk of early ovarian decline.
Lifestyle changes may support overall reproductive health but cannot significantly increase AMH. Early planning is more effective.
A simple blood test measures AMH levels. It can be performed any day of the menstrual cycle.
AMH and ovarian reserve testing provide valuable insights into fertility potential. While AMH levels do not guarantee pregnancy outcomes, they allow women to make informed decisions about family planning, fertility preservation, and assisted reproductive techniques. Early assessment empowers women to take proactive steps, ensuring better control over their reproductive journey.
If You Are Planning Pregnancy or Concerned About Fertility, Schedule a Consultation With Dr. Sangeeta Dubey. Early Assessment of AMH and Ovarian Reserve Can Help You Make Informed Decisions and Plan for a Healthy Future.